Passage Bio Inc (PASG)
Cours de l'action
Loading...
•
Achat
•
Vente
•
Achat planifié
•
Vente planifiée
Achat net
Vente nette
Résultats financiers
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | 2025-04-17 | V Vente | Actionnaire important |
1 000
-1.1%
0,3325 440 USD |
1 000 -1.1% | 0,33 | 100 000 USD | |
| 2025-04-17 | 2025-04-16 | V Vente | Actionnaire important |
1 000
-0.9%
0,3320 341 USD |
1 000 -0.9% | 0,33 | 100 000 USD | |
| 2025-04-17 | 2025-04-15 | V Vente | Actionnaire important |
1 000
-0.1%
0,383 924 USD |
1 000 -0.1% | 0,38 | 100 000 USD | |
| 2025-02-12 | 2025-02-11 | V Vente |
CFO Dirigeant |
3 183
-7.2%
0,531 686 USD |
3 183 -7.2% | 0,53 | 1 686 USD | |
| 2025-01-14 | 2025-01-14 | V Vente | Actionnaire important |
79 024
-1.1%
0,6047 414 USD |
79 024 -1.1% | 0,60 | 47 414 USD | |
| 2025-01-14 | 2025-01-13 | V Vente | Actionnaire important |
17 986
-0.3%
0,6411 511 USD |
17 986 -0.3% | 0,64 | 11 511 USD | |
| 2025-01-14 | 2025-01-10 | V Vente | Actionnaire important |
126 209
-1.7%
0,6683 298 USD |
126 209 -1.7% | 0,66 | 83 298 USD | |
| 2025-01-08 | 2025-01-08 | V Vente | Actionnaire important |
75 007
-1.0%
0,6851 005 USD |
75 007 -1.0% | 0,68 | 51 005 USD | |
| 2025-01-08 | 2025-01-07 | V Vente | Actionnaire important |
52 536
-0.7%
0,7137 301 USD |
52 536 -0.7% | 0,71 | 37 301 USD | |
| 2025-01-08 | 2025-01-06 | V Vente | Actionnaire important |
19 481
-0.3%
0,7715 000 USD |
19 481 -0.3% | 0,77 | 15 000 USD | |
| 2024-12-31 | 2024-12-27 | A Achat | Actionnaire important |
373 645
+4.2%
0,65241 038 USD |
373 645 +4.2% | 0,65 | 241 038 USD | |
| 2024-12-26 | 2024-12-20 | V Vente | Actionnaire important |
230 321
-3.0%
0,60138 193 USD |
230 321 -3.0% | 0,60 | 138 193 USD | |
| 2024-12-11 | 2024-12-11 | V Vente | Actionnaire important |
80
-0.0%
0,8064 USD |
80 -0.0% | 0,80 | 64 USD | |
| 2024-12-11 | 2024-12-10 | V Vente | Actionnaire important |
8 015
-0.1%
0,806 412 USD |
8 015 -0.1% | 0,80 | 6 412 USD | |
| 2024-12-11 | 2024-12-09 | V Vente | Actionnaire important |
54 181
-0.7%
0,8445 512 USD |
54 181 -0.7% | 0,84 | 45 512 USD | |
| 2024-12-06 | 2024-12-06 | V Vente | Actionnaire important |
20 903
-0.3%
0,8217 140 USD |
20 903 -0.3% | 0,82 | 17 140 USD | |
| 2024-12-06 | 2024-12-04 | V Vente | Actionnaire important |
76 200
-1.0%
0,7960 198 USD |
76 200 -1.0% | 0,79 | 60 198 USD | |
| 2024-11-27 | 2024-11-27 | A Achat | Actionnaire important |
29 300
+0.3%
0,6719 663 USD |
29 300 +0.3% | 0,67 | 19 663 USD | |
| 2024-11-27 | 2024-11-26 | A Achat | Actionnaire important |
167 055
+1.9%
0,71118 191 USD |
167 055 +1.9% | 0,71 | 118 191 USD | |
| 2024-11-27 | 2024-11-25 | A Achat | Actionnaire important |
259 998
+3.1%
0,56146 665 USD |
259 998 +3.1% | 0,56 | 146 665 USD | |
| 2024-09-23 | 2024-09-19 | V Vente | Actionnaire important |
39 300
-0.5%
0,7127 903 USD |
39 300 -0.5% | 0,71 | 27 903 USD | |
| 2024-09-18 | 2024-09-18 | V Vente | Actionnaire important |
25 631
-0.3%
0,7318 711 USD |
25 631 -0.3% | 0,73 | 18 711 USD | |
| 2024-09-18 | 2024-09-17 | V Vente | Actionnaire important |
111 400
-1.4%
0,7381 322 USD |
111 400 -1.4% | 0,73 | 81 322 USD | |
| 2024-09-18 | 2024-09-16 | V Vente | Actionnaire important |
63 100
-0.8%
0,7446 694 USD |
63 100 -0.8% | 0,74 | 46 694 USD | |
| 2024-02-13 | 2024-02-13 | V Vente |
SVP, INTERIM CFO Dirigeant |
1 470
-4.9%
0,971 426 USD |
1 470 -4.9% | 0,97 | 1 426 USD | |
| 2024-02-13 | 2024-02-13 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
1 638
-3.3%
0,971 589 USD |
1 638 -3.3% | 0,97 | 1 589 USD | |
| 2024-01-03 | 2024-01-02 | V Vente |
SVP, Interim CFO Dirigeant |
10 672
-29.2%
0,919 712 USD |
10 672 -29.2% | 0,91 | 9 712 USD | |
| 2024-01-03 | 2024-01-02 | V Vente |
Chief Medical Officer Dirigeant |
15 813
-25.9%
0,9114 390 USD |
15 813 -25.9% | 0,91 | 14 390 USD | |
| 2024-01-03 | 2024-01-02 | V Vente |
GC & Corporate Secretary Dirigeant |
15 813
-25.6%
0,9114 390 USD |
15 813 -25.6% | 0,91 | 14 390 USD | |
| 2023-08-01 | 2023-07-28 | V Vente |
Chief Financial Officer Dirigeant |
11 453
-32.3%
0,8810 079 USD |
11 453 -32.3% | 0,88 | 10 079 USD | |
| 2023-06-29 | 2023-06-28 | A Achat | Actionnaire important |
575 195
+7.7%
0,84483 164 USD |
575 195 +7.7% | 0,84 | 483 164 USD | |
| 2023-06-29 | 2023-06-27 | A Achat | Actionnaire important |
617 382
+9.0%
0,84518 601 USD |
617 382 +9.0% | 0,84 | 518 601 USD | |
| 2023-06-20 | 2023-06-16 | V Vente |
Chief Technical Officer Dirigeant |
4 052
-12.4%
0,933 778 USD |
4 052 -12.4% | 0,93 | 3 778 USD | |
| 2023-04-20 | 2023-04-18 | V Vente |
Chief Financial Officer Dirigeant |
2 053
-50.0%
1,052 156 USD |
2 053 -50.0% | 1,05 | 2 156 USD | |
| 2022-12-02 | 2022-12-01 | VP Vente planifiée | Administrateur non-exécutif |
5 000
-100.0%
1,195 965 USD |
5 000 -100.0% | 1,19 | 5 965 USD | |
| 2022-11-25 | 2022-11-22 | VP Vente planifiée |
Chief Technical Officer Dirigeant |
3 720
-15.5%
1,334 948 USD |
3 720 -15.5% | 1,33 | 4 948 USD | |
| 2022-11-18 | 2022-09-19 | V Vente |
Chief Commercial Officer Dirigeant |
1 681
-33.6%
1,512 539 USD |
1 681 -33.6% | 1,51 | 2 539 USD | |
| 2022-05-05 | 2022-05-04 | A Achat | Actionnaire important |
303 500
+4.6%
1,94588 790 USD |
303 500 +4.6% | 1,94 | 588 790 USD | |
| 2022-05-05 | 2022-05-03 | A Achat | Actionnaire important |
221 500
+3.5%
1,93427 495 USD |
221 500 +3.5% | 1,93 | 427 495 USD | |
| 2022-03-23 | 2022-03-21 | A Achat |
CEO and President Administrateur exécutif |
10 000
+167.1%
3,1531 500 USD |
10 000 +167.1% | 3,15 | 31 500 USD | |
| 2022-01-24 | 2022-01-20 | A Achat | Actionnaire important |
369 100
+5.9%
5,422 000 522 USD |
369 100 +5.9% | 5,42 | 2 000 522 USD | |
| 2022-01-20 | 2022-01-19 | A Achat | Actionnaire important |
43 300
+0.7%
5,11221 263 USD |
43 300 +0.7% | 5,11 | 221 263 USD | |
| 2022-01-20 | 2022-01-18 | A Achat | Actionnaire important |
114 700
+1.9%
5,46626 262 USD |
114 700 +1.9% | 5,46 | 626 262 USD | |
| 2022-01-20 | 2022-01-14 | A Achat | Actionnaire important |
10 300
+0.2%
5,6057 680 USD |
10 300 +0.2% | 5,60 | 57 680 USD | |
| 2022-01-13 | 2022-01-13 | A Achat | Actionnaire important |
41 800
+0.7%
5,52230 736 USD |
41 800 +0.7% | 5,52 | 230 736 USD | |
| 2022-01-13 | 2022-01-12 | A Achat | Actionnaire important |
100 000
+1.7%
5,65565 000 USD |
100 000 +1.7% | 5,65 | 565 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat | Actionnaire important |
8 200
+0.1%
5,5345 346 USD |
8 200 +0.1% | 5,53 | 45 346 USD | |
| 2021-05-21 | 2021-05-21 | AP Achat planifié |
CEO and President Administrateur exécutif |
2 000
+50.2%
13,1226 230 USD |
2 000 +50.2% | 13,12 | 26 230 USD | |
| 2021-03-17 | 2021-03-15 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
1 617
-100.0%
21,8635 350 USD |
1 617 -100.0% | 21,86 | 35 350 USD | |
| 2021-03-17 | 2021-03-15 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
8 383
-83.8%
20,95175 662 USD |
8 383 -83.8% | 20,95 | 175 662 USD | |
| 2021-01-22 | 2021-01-20 | VP Vente planifiée |
Chief Operating Officer Dirigeant |
1 300
-0.4%
30,0139 011 USD |
1 300 -0.4% | 30,01 | 39 011 USD | |
| 2020-03-25 | 2020-03-24 | A Achat | Administrateur non-exécutif |
10 000
+112.4%
14,98149 750 USD |
10 000 +112.4% | 14,98 | 149 750 USD | |
| 2020-03-03 | 2020-03-03 | A Achat | Administrateur non-exécutif |
5 000
+inf%
18,0090 000 USD |
5 000 +inf% | 18,00 | 90 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat |
Chief Technical Officer Dirigeant |
5 500
+inf%
18,0099 000 USD |
5 500 +inf% | 18,00 | 99 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat |
Versant Venture Capital VI, L.P. Actionnaire important |
225 000
+31.8%
18,004 050 000 USD |
225 000 +31.8% | 18,00 | 4 050 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat | Administrateur non-exécutif |
2 800
+inf%
18,0050 400 USD |
2 800 +inf% | 18,00 | 50 400 USD | |
| 2020-03-03 | 2020-03-03 | A Achat | Administrateur non-exécutif Actionnaire important |
550 000
+12.3%
18,009 900 000 USD |
550 000 +12.3% | 18,00 | 9 900 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat |
Chief Financial Officer Dirigeant |
400
+inf%
18,007 200 USD |
400 +inf% | 18,00 | 7 200 USD | |
| 2020-03-03 | 2020-03-03 | A Achat | Administrateur non-exécutif |
6 500
+1.0%
18,00117 000 USD |
6 500 +1.0% | 18,00 | 117 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat |
CEO and President Administrateur exécutif |
1 100
+inf%
18,0019 800 USD |
1 100 +inf% | 18,00 | 19 800 USD | |
| 2020-03-03 | 2020-03-03 | A Achat | Administrateur non-exécutif Actionnaire important |
225 000
+31.8%
18,004 050 000 USD |
225 000 +31.8% | 18,00 | 4 050 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat |
GC and Corporate Secretary Dirigeant |
2 000
+inf%
18,0036 000 USD |
2 000 +inf% | 18,00 | 36 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat |
Chief Operating Officer Dirigeant |
1 000
+inf%
18,0018 000 USD |
1 000 +inf% | 18,00 | 18 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat |
Chief Operating Officer Dirigeant |
1 500
+0.5%
18,0027 000 USD |
1 500 +0.5% | 18,00 | 27 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat | Administrateur non-exécutif |
8 900
+inf%
18,00160 200 USD |
8 900 +inf% | 18,00 | 160 200 USD | |
| 2020-03-03 | 2020-03-03 | A Achat |
Frazier Life Sciences IX, L.P. Actionnaire important |
550 000
+12.3%
18,009 900 000 USD |
550 000 +12.3% | 18,00 | 9 900 000 USD | |
| 2020-03-03 | 2020-03-03 | A Achat | Administrateur non-exécutif |
5 000
+inf%
18,0090 000 USD |
5 000 +inf% | 18,00 | 90 000 USD | |
| 2020-03-03 | 2020-02-28 | A Achat | Actionnaire important |
373 300
+inf%
18,006 719 400 USD |
373 300 +inf% | 18,00 | 6 719 400 USD |